Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features

Autor: Simon, Sylvain, Wu, Zhong, Cruard, J., Vignard, Virginie, Fortun, Agnes, Khammari, Amir, Dreno, Brigitte, Lang, Francois, Rulli, Samuel J., Labarriere, Nathalie

Publikováno v: Frontiers in Immunology
Frontiers in Immunology, 2018, 9, pp.1962. ⟨10.3389/fimmu.2018.01962⟩
Frontiers in Immunology, Frontiers, 2018, 9, pp.1962. ⟨10.3389/fimmu.2018.01962⟩

International audience; Among Immunotherapeutic approaches for cancer treatment, the adoptive transfer of antigen specific T cells is still a relevant approach, that could have higher efficacy when further combined with immune checkpoint blockade. A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d2be8f41d8b9ab2ff523e6f6201dd871
https://www.hal.inserm.fr/inserm-01885141

Site-Directed Mutagenesis of Cation Coordinating Residues in the Gastric H,K-ATPase

Autor: Rulli, Samuel J., Louneva, Natalya M., Skripnikova, Elena V., Rabon, Edd C.

Publikováno v: In Archives of Biochemistry and Biophysics 1 March 2001 387(1):27-34

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features.

Autor: Simon S; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology,' Nantes, France., Wu Z; Qiagen Sciences, Frederick, MD, United States., Cruard J; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology,' Nantes, France., Vignard V; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology,' Nantes, France.; Centre Hospitalier Universitaire Nantes, Nantes, France., Fortun A; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology,' Nantes, France., Khammari A; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology,' Nantes, France.; Department of Dermato-Cancerology of Nantes Hospital, Nantes, France., Dreno B; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology,' Nantes, France.; Department of Dermato-Cancerology of Nantes Hospital, Nantes, France., Lang F; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology,' Nantes, France., Rulli SJ; Qiagen Sciences, Frederick, MD, United States., Labarriere N; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology,' Nantes, France.; Centre Hospitalier Universitaire Nantes, Nantes, France.

Publikováno v: Frontiers in immunology [Front Immunol] 2018 Aug 30; Vol. 9, pp. 1962. Date of Electronic Publication: 2018 Aug 30 (Print Publication: 2018).